have been approved to treat renal cell carcinoma (RCC), and several other molecules are under investigation. However, lack of response to antiangiogenic drugs and adverse drug reactions leading to ...

Kidney cancer is the seventh most commonly diagnosed cancer in the UK, and renal cell carcinoma makes up 90 per cent of cases. While much of the risk comes from lifestyle factors, genetics also plays ...

More than 70 percent of Japanese renal cell carcinoma patients have a specific genetic mutation pattern that is rarely found in other countries, an international team of researchers said. The ...

Adjuvant IO: Survival Advantage 'Big News' in Renal Cancer A 40% reduced risk for death from renal cancer, as reported by KEYNOTE-564, tops Dr Brian Rini's list of takeaways from ASCO GU 2024.

(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, 2024, was host to the Kidney Cancer Session II. Dr Mark Ball discussed ...

"Among genitourinary tumors, renal cell carcinoma (RCC) has been the area of most clinical trial research into the gut microbiome since immunotherapy is a mainstay of treatment in RCC," said Ulka ...

Investigators studied the prevalence, predictors, and outcomes of complete functional recovery after radical nephrectomy.